Virologists at the KU Leuven Rega Institute have been working on two lines of SARS-CoV-2 research: searching for a vaccine to prevent infection, and testing existing drugs to see which one can reduce the amount of virus in infected people.
To test the efficacy of the vaccine and antivirals preclinically, the researchers use...
Hydroxychloroquine Doesn’t Counter SARS-CoV-2 In Hamsters, High Dose Of Favipiravir Does
Eurasia Review
0 shares
1 views
You might like
Related news coverage
Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study
Virologists have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus..
Science Daily